ACP Journal Club
17 April 2018

In COPD, new use of long-acting bronchodilators was linked to CV events at ≤ 30 days, but not > 30 days

Publication: Annals of Internal Medicine
Volume 168, Number 8

Abstract

Source Citation

Wang MT, Liou JT, Lin CW, et al. Association of cardiovascular risk with inhaled long-acting bronchodilators in patients with chronic obstructive pulmonary disease: a nested case–control study. JAMA Intern Med. 2018;178:229-38. https://pubmed.ncbi.nlm.nih.gov/29297057/

Abstract

Clinical Impact Ratings

GIM/FP/GP: 6 out of 7
Cardiology: 5 out of 7
Pulmonology: 6 out of 7

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Lahousse L, Verhamme KM, Stricker BH, Brusselle GG. Cardiac effects of current treatments of chronic obstructive pulmonary disease. Lancet Respir Med. 2016;4:149-64. [PMID: 26794033]
2.
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2018 report). www.goldcopd.org/gold-reports/ (accessed 12 Feb 2018).

Information & Authors

Information

Published In

cover image Annals of Internal Medicine
Annals of Internal Medicine
Volume 168Number 817 April 2018
Pages: JC47

History

Published online: 17 April 2018
Published in issue: 17 April 2018

Keywords

Authors

Affiliations

Matthew B. Stanbrook, MD, PhD
Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada (M.B.S.)
This article was published at Annals.org on 3 April 2018.

Metrics & Citations

Metrics

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format





Download article citation data for:
Matthew B. Stanbrook. In COPD, new use of long-acting bronchodilators was linked to CV events at ≤ 30 days, but not > 30 days. Ann Intern Med.2018;168:JC47. [Epub 17 April 2018]. doi:10.7326/ACPJC-2018-168-8-047

View More

Get Access

Login Options:
Purchase

You will be redirected to acponline.org to sign-in to Annals to complete your purchase.

Create your Free Account

You will be redirected to acponline.org to create an account that will provide access to Annals.

View options

PDF/ePub

View PDF/ePub

Related in ACP Journals

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media